Aspen Pharmacare (APNHY) Stock Statistics & Valuation Metrics

Aspen Pharmacare has a market cap or net worth of $3.50B. The enterprise value is $85.76B.

Aspen Pharmacare has 446,252,320 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aspen Pharmacare’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 1.17%.

The current PE Ratio of Aspen Pharmacare is 8.6. Aspen Pharmacare’s PEG ratio is 0.39.

In the last 12 months, Aspen Pharmacare had revenue of 43.36B and earned -1.08B in profits. Earnings per share was -2.44.

In the last 12 months, operating cash flow was 6.76B and capital expenditures -2.45B, giving a free cash flow of 4.31B billion.

Aspen Pharmacare pays an annual dividend of $0.122, resulting in a dividend yield of 2.15%

Aspen Pharmacare upcoming earnings date is Sep 2, 2026, TBA (Confirmed).

Aspen Pharmacare as a current ratio of 2.21, with Debt / Equity ratio of 40.63%

In the past 12 months, Aspen Pharmacare has paid 960.00M in taxes.

Aspen Pharmacare EV to EBITDA ratio is 38.42, with an EV/FCF ratio of 798.27.

Aspen Pharmacare has $5.61B in cash and marketable securities with $32.91B in debt, giving a net cash position of -$27.30B billion.

Gross margin is 41.91%, with operating margin of 3.31%, and net profit margin of -2.50%.

The average price target for Aspen Pharmacare is ―, which is 11.43% higher than the current price. The consensus rating is ―